Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway

Buformin has been reported to be a powerful anticancer drug by activating the AMPK signal. Herein, we aimed to investigate the effects of buformin on osteosarcoma.

Bibliographic Details
Main Authors: Ding Yan, Lv Shiqiao, Li Guangrun, Cui Jinpeng, Chen Yunzhen
Format: Article
Language:English
Published: De Gruyter 2020-06-01
Series:Open Life Sciences
Subjects:
buformin
osteosarcoma
ampk signal pathway
synergistic effect
Online Access:https://doi.org/10.1515/biol-2020-0041

Internet

https://doi.org/10.1515/biol-2020-0041

Similar Items